To Study the Effect of Vytorin on Intracellular Lipid and Inflammation in Obese Subjects

Trial Profile

To Study the Effect of Vytorin on Intracellular Lipid and Inflammation in Obese Subjects

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 17 Dec 2012

At a glance

  • Drugs Ezetimibe/simvastatin (Primary)
  • Indications Hyperlipidaemia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 17 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 05 Jun 2012 Planned End Date changed from 1 Dec 2011 to 1 Dec 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top